MedTrace Logo

Deep Friction Massage Effects: Asymptomatic

NCT03255525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-08-21

No results posted yet for this study

Summary

Despite DFM being a widely-used technique and the empirical grounding regarding the importance of the pressure applied, there is no study characterizing the pressure applied during DFM, remaining it a discretion of the physiotherapist. Additionally, it is not known how the amount of pressure applied may influence pain mechanisms and, consequently how it affects the time needed promote an analgesic response.

Having this, our general objective is to establish a dose-response relationship between the pressure applied during DFM and time of onset of analgesia, in the asymptomatic patellar tendon.

Conditions

  • Deep Friction Massage

Interventions

OTHER

Deep friction massage P50

Deep friction massage as described by Dr. James Cyriax, applied with the mean pressure (P50)

OTHER

Deep friction massage P25

Deep friction massage as described by Dr. James Cyriax, applied with the percentile 25 of the mean pressure (P25)

OTHER

Deep friction massage P75

Deep friction massage as described by Dr. James Cyriax, applied with the percentile 75 of the mean pressure (P75)

Sponsors & Collaborators

  • Cooperativa de Ensino Superior, Politécnico e Universitário

    lead OTHER

Principal Investigators

  • Maria A Paço, PhD · Cooperativa Ensino Superior Politécnico e Universitário

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-26
Primary Completion
2017-08-16
Completion
2017-08-16

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255525 on ClinicalTrials.gov